MSCI enters its July 21 earnings report with a notable shift in options sentiment — the clearest divergence from the cautious positioning that defined the stock through most of June.
Options traders have become markedly less defensive. The put/call ratio has dropped to 0.98, well below its 20-day average of 1.33 and roughly 1.7 standard deviations beneath it. That's a sharp reversal from late June, when the PCR ran as high as 1.66, near the most defensive readings of the past year. The move coincides with an 8.6% weekly gain to $608.09 — a recovery that appears to have prompted traders to unwind downside hedges rather than add new ones. The stock remains down about 1.2% over the past month, so the week's bounce partially restores lost ground rather than breaking into new territory.
The lending market tells a straightforward story: shorts have no meaningful foothold here. Short interest runs at just 2.4% of the free float, down about 2% week-on-week. Availability is extraordinarily loose at 9,724% — meaning the pool of shares available to borrow dwarfs the current short position by a factor of nearly 100. Borrowing costs have halved over the past week to just 0.36%, their lowest level in at least six weeks. The ORTEX short score of 33 corroborates this: it places MSCI firmly in the lower tier of short-selling pressure across the universe. Month-on-month, short interest has climbed about 27% in share terms — but from such a low base that the absolute level remains negligible. Positioning looks thin rather than crowded on the short side.
The Street is constructive and growing more so. Raymond James raised its price target to $760 this week, maintaining a Strong Buy — the most recent and highest target in the analyst set. The consensus mean target of $692 implies roughly 14% upside from current levels, with most of the recent flow running in an upward direction: Morgan Stanley and UBS both lifted targets after the last earnings print in April, and Wells Fargo upgraded to Overweight in late May. The bull case centres on roughly 19% AUM growth year-on-year and a structural tailwind from passive investing and index licensing. Bears focus on slowing net new subscriptions and a sharp drop in sustainable fund launches — concerns that the April print temporarily set aside with a 7.2% one-day move higher. Valuation is not cheap: the forward PE runs near 27x and EV/EBITDA near 21x, though neither has moved dramatically over the past 30 days. The EPS surprise factor score of 82 reflects a track record of beating estimates that the Street appears to be pricing in again.
The CEO's fingerprints are worth noting. Henry Fernandez bought just over 4,000 shares across multiple tranches on May 15 at prices around $560-$565, totalling roughly $2.25 million. That purchase came near the stock's monthly lows and is now sitting on a gain of roughly 8%. Net insider activity over the past 90 days amounts to nearly $8.7 million bought versus sold. The CFO did sell 450 shares in June, but at a fraction of the CEO's dollar commitment. Fernandez himself remains a top-five holder with nearly 3% of the company — a concentration that gives his buying activity more than ceremonial significance.
Close peers moved broadly in line this week. MCO rose 10.5%, FDS gained 10.6%, and SPGI added 8.5% — suggesting the week's move in MSCI reflects a sector-wide re-rating rather than a stock-specific catalyst. NDAQ led the group with a 12.5% gain. The prior earnings print on April 21 produced a 7.2% one-day advance and a further 4.9% over the following five days — the key question heading into July 21 is whether the subscription growth trajectory has continued to recover from the softness flagged in late 2024.
See the live data behind this article on ORTEX.
Open MSCI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
